Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pradefovir mesylate

Known as: hepavir-B, Remofovir Mesylate, 9-(2-(4-(3-chlorophenyl)-2-oxo-1,3,2-dioxaphosphorinan-2-yl)methoxyethyl)adenine 
The mesylate salt form of pradefovir, a cyclodiester antiviral prodrug with specific activity against hepatitis B virus (HBV). Pradefovir is… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND & AIMS People who inject drugs (PWID) and are on opioid agonist therapy (OAT) might have lower adherence to direct… Expand
Is this relevant?
2019
2019
Among patients with cirrhosis, recovery of liver function after SVR to all‐oral direct‐acting antivirals (DAA) in HIV/HCV… Expand
Is this relevant?
Review
2019
Review
2019
Varicella‐zoster virus and hepatitis B virus reactivations have been reported after starting interferon‐free direct‐acting… Expand
Is this relevant?
2016
2016
A rapid and sensitive liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of… Expand
Is this relevant?
2005
2005
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… Expand
Is this relevant?
2004
2004
Adefovir dipivoxil (Hepsera™), a first-line therapy for chronic hepatitis B, is an esterase-activated prodrug of PMEA. Dose… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?